Tectonic Advisors LLC Acquires 238 Shares of Danaher Co. (NYSE:DHR)

Tectonic Advisors LLC grew its stake in Danaher Co. (NYSE:DHR) by 7.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,350 shares of the conglomerate’s stock after acquiring an additional 238 shares during the period. Tectonic Advisors LLC’s holdings in Danaher were worth $769,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of DHR. Heck Capital Advisors LLC bought a new position in Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher in the fourth quarter valued at $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher during the third quarter worth $39,000. MidAtlantic Capital Management Inc. bought a new stake in Danaher during the third quarter worth $40,000. Finally, FSA Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at $50,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on DHR. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Robert W. Baird cut their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. UBS Group decreased their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Stephens reaffirmed an “overweight” rating and set a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Finally, Raymond James reiterated a “market perform” rating on shares of Danaher in a report on Monday. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Danaher stock opened at $211.92 on Thursday. The stock has a fifty day moving average of $234.50 and a 200-day moving average of $252.68. The stock has a market capitalization of $153.07 billion, a P/E ratio of 40.14, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52 week low of $210.04 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the business posted $2.09 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.51%. Danaher’s dividend payout ratio is presently 20.45%.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 10.90% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.